Clinical Trial Update: Injectable Platelet Rich Fibrin Versus Platelet Rich Plasma Injection in Degenerative Temporomandibular Joint [NA]

View source ↗

Summary

A completed clinical trial comparing injectable platelet-rich fibrin versus platelet-rich plasma injections for degenerative temporomandibular joint disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temporomandibular Joint Disorders

Drugs mentioned

• Platelet Rich Fibrin (platelet-rich fibrin)
• Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Nasser Institute For Research and Treatment | Conditions: Platelet Rich Fibrin, Platelet Rich Plasma Injection | NA | Status: COMPLETED